Close Menu

This story has been updated with additional information from Abbott's earnings call. 

NEW YORK – Abbott on Thursday said that its Diagnostics business revenues grew 5 percent year over year in the second quarter, while its total revenues were down 8 percent.

For the three months ended June 30, the Abbott Park, Illinois-based firm reported overall Q2 revenues of $7.33 billion, down from $7.98 billion in Q2 2019, and down 5 percent on an organic basis. The company beat the consensus Wall Street estimate of $6.75 billion.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.